Whilst the preservation of glycolysis contributes to reduced clinical severity, undiagnosed FBP1 deficiency is potentially fatal, particular if fructose, sucrose or glycerol containing intravenous solutions are used to manage acute crises or ensuing complications such as cerebral oedema.6, 12. This evidence concerns the gene FBP1 and cerebral palsy.